These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16294196)
1. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM Mod Pathol; 2006 Jan; 19(1):97-105. PubMed ID: 16294196 [TBL] [Abstract][Full Text] [Related]
2. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188 [TBL] [Abstract][Full Text] [Related]
3. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
4. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM Int J Gynecol Pathol; 2006 Jan; 25(1):83-9. PubMed ID: 16306790 [TBL] [Abstract][Full Text] [Related]
5. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Cao D; Ji H; Ronnett BM Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919 [TBL] [Abstract][Full Text] [Related]
6. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Vang R; Gown AM; Wu LS; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Mod Pathol; 2006 Nov; 19(11):1421-8. PubMed ID: 16980943 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. McCluggage WG J Clin Pathol; 2012 Jul; 65(7):596-600. PubMed ID: 21768188 [TBL] [Abstract][Full Text] [Related]
9. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622 [TBL] [Abstract][Full Text] [Related]
10. SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases. Schmoeckel E; Kirchner T; Mayr D Pathol Res Pract; 2018 Mar; 214(3):426-430. PubMed ID: 29487003 [TBL] [Abstract][Full Text] [Related]
11. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis. Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191 [TBL] [Abstract][Full Text] [Related]
12. Pathology of primary and metastatic mucinous ovarian neoplasms. Leen SL; Singh N J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620 [TBL] [Abstract][Full Text] [Related]
14. Expression profile of mucins in ovarian mucinous tumors: distinguishing primary ovarian from metastatic tumors. Wang J; El-Bahrawy MA Int J Gynecol Pathol; 2014 Mar; 33(2):166-75. PubMed ID: 24487472 [TBL] [Abstract][Full Text] [Related]
15. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780 [TBL] [Abstract][Full Text] [Related]
16. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors. Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675 [TBL] [Abstract][Full Text] [Related]
18. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining. Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987 [TBL] [Abstract][Full Text] [Related]
20. HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis. Kim SK; Cho NH Int J Clin Exp Pathol; 2014; 7(7):4222-30. PubMed ID: 25120802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]